Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Monique Spillman

Concepts (262)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2023
449
1.870
 Why?
Endometrial Neoplasms
5
2015
137
0.850
 Why?
Gynecology
5
2020
48
0.810
 Why?
Genital Neoplasms, Female
2
2020
41
0.760
 Why?
Gene Expression Regulation, Neoplastic
10
2019
831
0.750
 Why?
Cystadenocarcinoma, Serous
4
2021
71
0.710
 Why?
Infection Control
1
2020
47
0.670
 Why?
Ethics, Medical
1
2020
46
0.660
 Why?
Communication
1
2020
256
0.590
 Why?
Conflict of Interest
3
2016
25
0.580
 Why?
Uterus
1
2018
84
0.570
 Why?
Medical Oncology
3
2020
97
0.570
 Why?
Robotics
2
2014
41
0.550
 Why?
Pneumonia, Viral
1
2020
169
0.550
 Why?
Peptides
3
2015
220
0.540
 Why?
Coronavirus Infections
1
2020
176
0.540
 Why?
Receptors, Estrogen
5
2017
132
0.530
 Why?
Medroxyprogesterone Acetate
1
2015
6
0.510
 Why?
Fallopian Tube Neoplasms
2
2013
14
0.510
 Why?
Pandemics
1
2020
553
0.490
 Why?
Antineoplastic Agents, Hormonal
1
2015
49
0.490
 Why?
Glycoproteins
1
2015
116
0.480
 Why?
Gynecologic Surgical Procedures
2
2014
29
0.480
 Why?
Neoplastic Stem Cells
1
2015
97
0.470
 Why?
Adenocarcinoma
2
2015
396
0.460
 Why?
Antigens, CD
1
2015
221
0.460
 Why?
Female
34
2023
27053
0.420
 Why?
MicroRNAs
4
2021
345
0.420
 Why?
Salpingectomy
1
2013
6
0.420
 Why?
General Surgery
1
2014
105
0.410
 Why?
Pelvic Neoplasms
1
2013
14
0.410
 Why?
Peritoneal Neoplasms
2
2011
63
0.410
 Why?
Estrogens
2
2012
225
0.400
 Why?
Clinical Trials as Topic
2
2007
488
0.380
 Why?
Medicare Part B
1
2011
5
0.380
 Why?
Professional Corporations
1
2011
1
0.380
 Why?
Marketing of Health Services
1
2011
7
0.370
 Why?
Reimbursement Mechanisms
1
2011
22
0.370
 Why?
Physicians
2
2016
235
0.370
 Why?
Cell Line, Tumor
11
2016
1393
0.370
 Why?
Social Responsibility
1
2011
26
0.370
 Why?
Receptors, Progesterone
4
2015
64
0.370
 Why?
Trust
1
2011
60
0.360
 Why?
Humans
42
2023
50419
0.360
 Why?
Carcinoma, Large Cell
1
2010
15
0.350
 Why?
Carcinoma, Neuroendocrine
1
2010
22
0.350
 Why?
Interprofessional Relations
1
2011
82
0.350
 Why?
Health Care Reform
1
2010
22
0.340
 Why?
Physician-Patient Relations
1
2011
143
0.330
 Why?
Breast Neoplasms
4
2012
1198
0.320
 Why?
Uterine Neoplasms
2
2019
60
0.300
 Why?
Transplantation, Heterologous
2
2012
73
0.290
 Why?
Uterine Cervical Neoplasms
1
2010
275
0.290
 Why?
Physician's Role
2
2011
47
0.280
 Why?
MAP Kinase Kinase 4
1
2007
29
0.270
 Why?
Apoptosis
5
2016
1092
0.270
 Why?
Genes, Tumor Suppressor
1
2007
73
0.270
 Why?
Patient Dropouts
1
2007
51
0.270
 Why?
Advance Directives
1
2007
29
0.270
 Why?
Gene Expression Regulation, Enzymologic
1
2007
178
0.250
 Why?
Receptors, Transforming Growth Factor beta
1
2005
25
0.240
 Why?
Claudin-4
2
2016
7
0.240
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
997
0.230
 Why?
Ovary
1
2004
114
0.230
 Why?
Hysterectomy
2
2014
88
0.220
 Why?
Epithelial Cells
1
2004
203
0.210
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2017
568
0.210
 Why?
Aged
11
2021
9738
0.200
 Why?
Neoplasm Staging
4
2021
738
0.200
 Why?
Middle Aged
12
2021
12579
0.190
 Why?
Gene Expression Profiling
3
2019
1020
0.190
 Why?
Cisplatin
2
2015
283
0.180
 Why?
Immunohistochemistry
6
2017
955
0.180
 Why?
Cell Movement
3
2016
244
0.170
 Why?
Standard of Care
1
2020
17
0.170
 Why?
Resource Allocation
1
2020
17
0.170
 Why?
Disclosure
2
2016
39
0.170
 Why?
Loss of Heterozygosity
2
2013
75
0.170
 Why?
Lymphatic Metastasis
2
2010
221
0.160
 Why?
Early Detection of Cancer
1
2021
162
0.160
 Why?
Leiomyosarcoma
1
2019
20
0.160
 Why?
Leiomyoma
1
2019
24
0.160
 Why?
Neoplasm Invasiveness
3
2015
269
0.160
 Why?
Xenograft Model Antitumor Assays
4
2012
210
0.150
 Why?
RNA-Binding Proteins
2
2019
116
0.150
 Why?
Informed Consent
3
2004
96
0.150
 Why?
Death
1
2018
21
0.150
 Why?
Living Donors
1
2018
24
0.150
 Why?
Critical Care
1
2020
214
0.150
 Why?
Neoplasms, Glandular and Epithelial
2
2015
41
0.150
 Why?
Palliative Care
1
2020
191
0.150
 Why?
Carcinosarcoma
1
2017
18
0.140
 Why?
Microfilament Proteins
1
2017
42
0.140
 Why?
Sequence Analysis, RNA
1
2017
87
0.130
 Why?
United States
4
2016
5005
0.130
 Why?
Adult
7
2021
13561
0.130
 Why?
Mice, Nude
3
2012
247
0.130
 Why?
Industry
1
2016
17
0.130
 Why?
Carrier Proteins
1
2017
297
0.130
 Why?
Keratin-5
1
2015
1
0.130
 Why?
Receptors, Androgen
1
2015
45
0.120
 Why?
Cell Count
1
2015
150
0.120
 Why?
Cell Proliferation
4
2015
980
0.120
 Why?
Prognosis
4
2017
1974
0.120
 Why?
Neoplasm Seeding
1
2014
4
0.120
 Why?
Genetic Privacy
2
2004
3
0.110
 Why?
Alanine
1
2014
43
0.110
 Why?
Triazines
1
2014
24
0.110
 Why?
Endometrium
1
2014
40
0.110
 Why?
Mice
6
2016
5659
0.110
 Why?
Genes, BRCA2
1
2013
12
0.110
 Why?
Genes, BRCA1
1
2013
19
0.110
 Why?
Insurance, Health, Reimbursement
1
2013
24
0.100
 Why?
Health Care Costs
2
2013
171
0.100
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
7
0.100
 Why?
DNA Methylation
3
2023
548
0.100
 Why?
Risk Reduction Behavior
1
2013
58
0.100
 Why?
Carcinoma, Lobular
1
2012
32
0.100
 Why?
DNA-Binding Proteins
2
2013
410
0.100
 Why?
Paclitaxel
1
2012
84
0.100
 Why?
Lymph Nodes
1
2014
256
0.100
 Why?
Antibodies, Neoplasm
1
2012
28
0.100
 Why?
Coercion
1
2011
6
0.100
 Why?
Judicial Role
1
2011
6
0.100
 Why?
Medicare Payment Advisory Commission
1
2011
2
0.100
 Why?
Personal Autonomy
1
2011
15
0.090
 Why?
Women
1
2011
29
0.090
 Why?
Prejudice
1
2011
39
0.090
 Why?
Politics
1
2011
27
0.090
 Why?
Homeodomain Proteins
1
2012
79
0.090
 Why?
Quality of Health Care
1
2013
183
0.090
 Why?
Violence
1
2011
59
0.090
 Why?
M Phase Cell Cycle Checkpoints
1
2011
4
0.090
 Why?
Taxoids
1
2011
37
0.090
 Why?
RNA, Messenger
2
2012
1085
0.090
 Why?
Selective Estrogen Receptor Modulators
1
2010
24
0.090
 Why?
Organ Specificity
1
2010
109
0.090
 Why?
Obstetrics
1
2011
85
0.090
 Why?
Immunoenzyme Techniques
1
2010
140
0.090
 Why?
Models, Statistical
1
2011
224
0.090
 Why?
Cesarean Section
1
2011
155
0.090
 Why?
Neoplasm Recurrence, Local
1
2014
622
0.080
 Why?
Alcohol Drinking
1
2011
228
0.080
 Why?
Societies, Medical
1
2010
189
0.080
 Why?
Blotting, Western
1
2010
575
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
400
0.080
 Why?
Transfection
2
2012
353
0.080
 Why?
Phosphorylation
2
2008
520
0.080
 Why?
Animals
6
2016
13063
0.080
 Why?
Aging
1
2013
692
0.070
 Why?
Aged, 80 and over
4
2021
3233
0.070
 Why?
Alleles
2
2006
252
0.070
 Why?
Antineoplastic Agents
1
2015
1165
0.070
 Why?
Case-Control Studies
2
2014
1152
0.070
 Why?
Chimera
1
2007
10
0.070
 Why?
CpG Islands
1
2007
107
0.070
 Why?
MAP Kinase Signaling System
1
2007
117
0.060
 Why?
Genomic Imprinting
1
2006
8
0.060
 Why?
Insulin-Like Growth Factor II
1
2006
16
0.060
 Why?
RNA, Untranslated
1
2006
12
0.060
 Why?
Health Services Accessibility
1
2010
426
0.060
 Why?
Base Sequence
1
2007
622
0.060
 Why?
Molecular Sequence Data
1
2007
760
0.060
 Why?
Repetitive Sequences, Amino Acid
1
2005
1
0.060
 Why?
Models, Biological
2
2008
717
0.060
 Why?
North Carolina
1
2005
57
0.060
 Why?
Databases, Nucleic Acid
1
2004
8
0.060
 Why?
Telomerase
1
2004
25
0.060
 Why?
Carcinoma
1
2006
137
0.060
 Why?
Promoter Regions, Genetic
1
2007
455
0.060
 Why?
Polymorphism, Genetic
1
2005
177
0.060
 Why?
RNA, Small Interfering
2
2016
208
0.060
 Why?
RNA Interference
2
2016
179
0.060
 Why?
Tumor Burden
2
2016
130
0.060
 Why?
Cell Survival
2
2016
587
0.060
 Why?
Family Health
1
2004
76
0.050
 Why?
Genetic Counseling
1
2004
41
0.050
 Why?
Genomics
1
2004
238
0.050
 Why?
Epigenesis, Genetic
1
2006
371
0.050
 Why?
Researcher-Subject Relations
1
2002
1
0.050
 Why?
Ethical Review
1
2002
2
0.050
 Why?
Contract Services
1
2002
13
0.050
 Why?
Financial Support
1
2002
3
0.050
 Why?
Genetic Predisposition to Disease
1
2005
507
0.050
 Why?
Cell Line
1
2004
997
0.050
 Why?
Biotechnology
1
2002
13
0.050
 Why?
Mice, SCID
2
2012
171
0.050
 Why?
Health Care Sector
1
2002
15
0.050
 Why?
Drug Industry
1
2002
38
0.050
 Why?
Research Support as Topic
1
2002
45
0.050
 Why?
Research Subjects
1
2002
50
0.050
 Why?
Neoplasm Grading
1
2021
122
0.040
 Why?
Patient Selection
1
2002
257
0.040
 Why?
Cooperative Behavior
1
2002
225
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
9
0.040
 Why?
Cytoskeletal Proteins
1
2019
47
0.040
 Why?
Risk Assessment
1
2023
1268
0.040
 Why?
Microtubule-Associated Proteins
1
2019
66
0.040
 Why?
Biomedical Research
1
2002
243
0.040
 Why?
Cell Cycle Proteins
1
2019
163
0.040
 Why?
Cohort Studies
1
2021
1451
0.030
 Why?
Sensitivity and Specificity
1
2019
855
0.030
 Why?
Caspase 3
1
2016
93
0.030
 Why?
Retrospective Studies
2
2021
6274
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Diagnosis, Differential
1
2019
1029
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2015
51
0.030
 Why?
Prospective Studies
1
2021
2378
0.030
 Why?
Exosomes
1
2015
47
0.030
 Why?
HEK293 Cells
1
2015
209
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2014
10
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
182
0.030
 Why?
Peritoneal Cavity
1
2014
8
0.030
 Why?
Risk Factors
2
2014
3712
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2014
180
0.030
 Why?
Drug Resistance, Neoplasm
1
2015
315
0.030
 Why?
Disease-Free Survival
1
2014
439
0.030
 Why?
MCF-7 Cells
1
2013
62
0.030
 Why?
Germ-Line Mutation
1
2013
61
0.030
 Why?
Homologous Recombination
1
2013
41
0.030
 Why?
Amino Acid Substitution
1
2013
81
0.030
 Why?
Karyotyping
1
2012
65
0.030
 Why?
Extracellular Matrix Proteins
1
2013
66
0.030
 Why?
Anoikis
1
2012
8
0.030
 Why?
Databases, Factual
1
2016
676
0.030
 Why?
Transduction, Genetic
1
2012
45
0.030
 Why?
Tubulin
1
2012
19
0.030
 Why?
Signal Transduction
2
2011
1608
0.020
 Why?
Mice, Inbred NOD
1
2012
89
0.020
 Why?
Tamoxifen
1
2012
61
0.020
 Why?
DNA Fingerprinting
1
2012
55
0.020
 Why?
Cell Adhesion
1
2012
155
0.020
 Why?
Antibody Specificity
1
2012
34
0.020
 Why?
Amino Acid Sequence
1
2013
575
0.020
 Why?
Perioperative Period
1
2011
21
0.020
 Why?
Tumor Suppressor Protein p53
1
2013
212
0.020
 Why?
Disease Models, Animal
1
2016
1431
0.020
 Why?
Estradiol
1
2012
221
0.020
 Why?
Microtubules
1
2011
40
0.020
 Why?
Cell Cycle Checkpoints
1
2011
29
0.020
 Why?
Gene Expression
1
2013
605
0.020
 Why?
Regression Analysis
1
2011
376
0.020
 Why?
Mitosis
1
2011
87
0.020
 Why?
HeLa Cells
1
2011
257
0.020
 Why?
Disease Progression
1
2012
825
0.020
 Why?
Cells, Cultured
1
2013
1563
0.020
 Why?
Severity of Illness Index
1
2011
976
0.020
 Why?
Progesterone Congeners
1
2008
5
0.020
 Why?
Progesterone
1
2008
60
0.020
 Why?
Mutation
1
2013
1275
0.020
 Why?
Protein Kinases
1
2008
68
0.020
 Why?
Cell Nucleus
1
2008
183
0.020
 Why?
Tumor Cells, Cultured
1
2008
453
0.020
 Why?
Transcriptional Activation
1
2006
120
0.020
 Why?
DNA, Neoplasm
1
2006
144
0.020
 Why?
Protein Structure, Tertiary
1
2006
241
0.020
 Why?
Binding Sites
1
2006
362
0.010
 Why?
Repressor Proteins
1
2006
149
0.010
 Why?
Pregnancy
1
2011
2444
0.010
 Why?
Truth Disclosure
1
2004
14
0.010
 Why?
Genetic Diseases, Inborn
1
2004
20
0.010
 Why?
Male
1
2011
25866
0.010
 Why?
Spillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (262) concept(s)
_
Similar People Expand Description
See all (39) people
_